Peptide Comparison
Pal-AHK vs Rigin
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Pal-AHK and Rigin share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Pal-AHK | Rigin | |
|---|---|---|
| Class | Cosmetic lipopeptide (hair) | Cosmetic lipopeptide (anti-inflammatory) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Palmitoyl-modified AHK for enhanced skin/scalp penetration; angiogenic signaling | Suppresses IL-6 secretion by fibroblasts; reduces inflammaging |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 0.1-1% | Topical 2-4% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 2 indexed | 31 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Pal-AHK or Rigin?
Pal-AHK and Rigin share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.
What is the difference between Pal-AHK and Rigin?
Pal-AHK is classed as Cosmetic lipopeptide (hair); Rigin is classed as Cosmetic lipopeptide (anti-inflammatory). Reported mechanism: Pal-AHK, Palmitoyl-modified AHK for enhanced skin/scalp penetration; angiogenic signaling; Rigin, Suppresses IL-6 secretion by fibroblasts; reduces inflammaging. Reported half-life: Pal-AHK, Topical; Rigin, Topical. Routes in published studies: Pal-AHK, Topical; Rigin, Topical.
Which has stronger evidence, Pal-AHK or Rigin?
Pal-AHK and Rigin sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Pal-AHK is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 2 indexed studies. Rigin is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 31 indexed studies.
Which is more accessible, Pal-AHK or Rigin?
Neither Pal-AHK nor Rigin is an FDA-approved drug. Catalog status: Pal-AHK, Cosmetic; Rigin, Cosmetic.
Are Pal-AHK and Rigin ever combined?
Pal-AHK and Rigin appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…